NCT04690348View on ClinicalTrials.gov

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Recurrent Brain Metastases
Interventions
PROCEDURE

Craniotomy

Craniotomy

RADIATION

Cesium-131 brachytherapy

Intracavitary Cesium-131 brachytherapy

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack (Consent Only), Commack

33143

RECRUITING

Baptist Health South Florida, Miami

48202

NOT_YET_RECRUITING

Henry Ford Hospital, Detroit

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Consent Only), Middletown

Sponsors
All Listed Sponsors
collaborator

GT Medical Technologies, Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER